| ISIN | LU2492015610 |
|---|---|
| Valor Number | 120608809 |
| Bloomberg Global ID | |
| Fund Name | Kieger Sustainable Healthcare Fund Class A CHF (H) Accumulating |
| Fund Provider |
Kieger AG
Kieger AG Limmatstrasse 264, CH-8005 Zürich Phone: +41 44 444 18 44 Web: https://kieger.com/ E-Mail: info@kieger.com |
| Fund Provider | Kieger AG |
| Representative in Switzerland |
ACOLIN Fund Services AG Zürich Phone: +41 44 396 96 96 |
| Distributor(s) | |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Accumulation |
| Home Country | Luxembourg |
| Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | The investment objective of the Sub-Fund is to achieve long term capital growth by principally investing in equities of healthcare and healthcare related issuers worldwide (including Emerging Markets). The Sub-Fund aims to have a positive impact on society by investing in sustainable companies with current or future activities positively contributing to good health and well-being. The objective is reached by investing in innovative companies with differentiated products and/or services that are leaders in sustainability as identified through a proprietary sustainability framework developed by the Investment Manager. |
| Peculiarities |
| Current Price * | 98.21 CHF | 27.10.2025 |
|---|---|---|
| Previous Price * | 97.95 CHF | 24.10.2025 |
| 52 Week High * | 105.77 CHF | 28.10.2024 |
| 52 Week Low * | 89.41 CHF | 07.08.2025 |
| NAV * | 98.21 CHF | 27.10.2025 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 177,594,250 | |
| Unit/Share Assets *** | 1,019,524 | |
| Trading Information SIX | ||
| YTD Performance | +1.37% |
31.12.2024 - 27.10.2025
31.12.2024 27.10.2025 |
|---|---|---|
| 1 month | +6.24% |
29.09.2025 - 27.10.2025
29.09.2025 27.10.2025 |
| 3 months | +2.81% |
28.07.2025 - 27.10.2025
28.07.2025 27.10.2025 |
| 6 months | +1.28% |
28.04.2025 - 27.10.2025
28.04.2025 27.10.2025 |
| 1 year | -7.15% |
28.10.2024 - 27.10.2025
28.10.2024 27.10.2025 |
| 2 years | +10.55% |
27.10.2023 - 27.10.2025
27.10.2023 27.10.2025 |
| 3 years | +5.64% |
27.10.2022 - 27.10.2025
27.10.2022 27.10.2025 |
| 5 years | -1.79% |
04.08.2022 - 27.10.2025
04.08.2022 27.10.2025 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Eli Lilly and Co | 6.32% | |
|---|---|---|
| AstraZeneca PLC | 5.81% | |
| Abbott Laboratories | 5.56% | |
| Roche Holding AG | 5.37% | |
| Novartis AG Registered Shares | 5.22% | |
| Boston Scientific Corp | 4.44% | |
| Vertex Pharmaceuticals Inc | 3.92% | |
| UnitedHealth Group Inc | 3.70% | |
| Danaher Corp | 3.52% | |
| Stryker Corp | 3.46% | |
| Last data update | 31.07.2025 | |
| TER | |
|---|---|
| TER date | |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 0.85% |
| Ongoing Charges *** | 1.05% |
|
SRRI ***
|
|
| SRRI date *** | 30.04.2024 |